Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02995837 · ClinicalTrials.gov registry record

Cerebral Blood Flow and Childhood Obstructive Sleep Apnea

A clinical trial, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
47
Enrollment target

NCT02995837: Completed study, sponsored by Children's Hospital of Philadelphia.

NCT02995837 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02995837 has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
47 participants
Enrollment target

Study Summary

Obstructive sleep apnea syndrome (OSAS) causes hypoxemia and hypercapnia, which may impair cerebral blood flow and cause deficits in behavior. This is a case-control study designed to investigate cerebral blood flow and neurocognitive function in children with OSAS when compared to these findings from normal children. The study hypothesis is that children with OSAS have an impaired cerebral blood flow during wakefulness and sleep compared to normal controls, and that the degree of this impairment correlates with neurocognitive function.

Primary Outcome

To determine whether children with OSAS have impaired blood flow regulation elicited by hypercapneic challenge compared to normal controls at baseline.

Interventions

  • OTHER Neurocognitive Testing
  • OTHER Sleep Study
  • OTHER CBF During Wakefulness
  • OTHER CBF During Sleep

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2016-10
Est. Completion 2022-01-01
Children's Hospital of Philadelphia

431 total trials

What the finished NCT02995837 record still lists

NCT02995837 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.

The record links to 0 conditions, and to 4 interventions - of which Neurocognitive Testing is the first listed.

NCT02995837 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02995837 about?

NCT02995837 is a clinical study titled "Cerebral Blood Flow and Childhood Obstructive Sleep Apnea". Obstructive sleep apnea syndrome (OSAS) causes hypoxemia and hypercapnia, which may impair cerebral blood flow and cause deficits in behavior. This is a case-control study designed to investigate cerebral blood flow and neurocognitive function in children with OSAS when compared to these findings fr...

What is the current status of trial NCT02995837?

This trial is currently completed. The enrollment target is 47 participants. The study started on 2016-10. Estimated completion is 2022-01-01.

What interventions are being tested in trial NCT02995837?

The interventions under investigation include: Neurocognitive Testing (OTHER), Sleep Study (OTHER), CBF During Wakefulness (OTHER), CBF During Sleep (OTHER).

Who is sponsoring clinical trial NCT02995837?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02995837, the US trial registry maintained by the National Library of Medicine. NCT02995837 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.